- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04748497
Performance Assessement for Paralympic Athletes (PARAPERF)
21. mars 2022 oppdatert av: Assistance Publique - Hôpitaux de Paris
Evaluation of Performance in Paralympic Athletes: Performance Outcomes in Sports
The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes.
The secondary objectives of the study:
- quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions;
- quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions;
- quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment;
- quantification and mechanical monitoring by the made-to-measure or usual sportive material.
Studieoversikt
Status
Rekruttering
Intervensjon / Behandling
Detaljert beskrivelse
The sportive performance results from a range of determinations such as: physiological, biomechanical, morphological, psychological, social and environmental factors.
The interactions between athletes, equipment, training and environment influences the development of athletes' performance.
In the context of the coming Paris 2024 Paralympic Games, the performance construction for the exploration, the quantification and the management of all factors is an commun objective between sportive team, medical team and researchers.
Studietype
Intervensjonell
Registrering (Forventet)
134
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Jean François Toussaint, MD, PhD
- Telefonnummer: +33 (0)1 42 34 82 10
- E-post: jean-francois.toussaint@aphp.fr
Studer Kontakt Backup
- Navn: François Genêt, MD, PhD
- Telefonnummer: +33 (0)1.47.10.70.68
- E-post: francois.genet@aphp.fr
Studiesteder
-
-
-
Garches, Frankrike, 92380
- Rekruttering
- Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
14 år og eldre (Barn, Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- High-lever paralympic athletes registered on the ministerial list or selected by Parasport Federation of France or Shooting Federation of France;
- Aged >= 14 years;
- Informed consent signed by adult athlete or by holder of parental authority or guardian for minor athlete;
- Covered by social security system.
Exclusion Criteria:
- Temporary or definitive contraindication to the practice of the affected sport activity;
- Undergoing anti-coagulated treatments;
- Cognitive disabilities conducting impossibility to participating to clinical trial, such as serious cognitive troubles, behaviors troubles, psychic troubles or upgraded curatorship needing;
- Under guardianship or judicial decision;
- Ongoing pregnancy.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Parasportives of various disciplines
|
Standardization of evaluation and clinical and sportive follow-up of athletes. Made-to-measure technical supports will be tested regarding the Paralympic regulations. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Dynamic sportive activity
Tidsramme: through study completion, an average of 1 year
|
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
|
through study completion, an average of 1 year
|
|
Dynamic sportive activity
Tidsramme: at 42 months
|
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
|
at 42 months
|
|
Static sportive activity
Tidsramme: through study completion, an average of 1 year
|
Static sportive activity: maximal speed of movement of pression center.
|
through study completion, an average of 1 year
|
|
Static sportive activity
Tidsramme: at 42 months
|
Static sportive activity: maximal speed of movement of pression center.
|
at 42 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Biomechanical indices of performance: isometric power measurement
Tidsramme: through study completion, an average of 1 year
|
Isometric power will be measured by MicroFet & handgrip of 26 measures, advice for healthcare professionals to measure handgrip strength forces to test and document grip deficits and to evaluate consistency of effort.
|
through study completion, an average of 1 year
|
|
Biomechanical indices of performance: arms and shoulder's Strength
Tidsramme: through study completion, an average of 1 year
|
Arms and shoulder's Strength will be measured by force platform.
|
through study completion, an average of 1 year
|
|
Physiological indices of performance: maximal aerobic speed (MAS)
Tidsramme: Twice through study completion, an average of 42 months
|
Maximal aerobic speed (MAS) will be measured by Repetition Per Minute on a Arm ergometer.
|
Twice through study completion, an average of 42 months
|
|
Physiological indices of performance: maximal aerobic power
Tidsramme: Twice through study completion, an average of 42 months
|
Maximal aerobic power will be measured by following Watts fluctuation during the incremental hand-biking test.
|
Twice through study completion, an average of 42 months
|
|
Fatigue assessment
Tidsramme: Twice through study completion, an average of 42 months
|
Fatigue assessment will be measured by Fatigue Index (Power max ratio).
|
Twice through study completion, an average of 42 months
|
|
Blood lactate concentration
Tidsramme: immediately after the intervention
|
Blood lactatemia level will be measured by lactometer.
|
immediately after the intervention
|
|
VO2 peak oxygen uptake
Tidsramme: through study completion, an average of 1 year
|
VO2 peak oxygen uptake
|
through study completion, an average of 1 year
|
|
Peak breath expiration volume assessment
Tidsramme: through study completion, an average of 1 year
|
VE peak: peak breath expiration volume
|
through study completion, an average of 1 year
|
|
Peak cardiac frequence
Tidsramme: through study completion, an average of 1 year
|
CF: peak cardiac frequence
|
through study completion, an average of 1 year
|
|
Musculo-squeletic troubles risks measurement
Tidsramme: through study completion, an average of 1 year
|
Musculo-squeletic troubles risks will be measured by medical following and clinical method of functional assessment of the shoulder (i.e.
"Constant scale").
|
through study completion, an average of 1 year
|
|
Time and distance of deceleration of wheelchair during riding test
Tidsramme: through study completion, an average of 1 year
|
Time and distance of deceleration of wheelchair during riding test: measured by signal analysis of instrumented wheelchair (inertial control units).
|
through study completion, an average of 1 year
|
|
Mechanical indices of wheelchair propulsion - applied forces on handrim during the propulsion
Tidsramme: through study completion, an average of 1 year
|
Applied forces on handrim during the propulsion: measured by force platform.
|
through study completion, an average of 1 year
|
|
Acceleration profil during the propulsion
Tidsramme: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
|
|
Speed profil during the propulsion
Tidsramme: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: François Genêt, MD, PhD, Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
- Studieleder: Jean François Toussaint, MD, PhD, Centre d'Investigation en Médecine du Sport, Hôpital Hôtel Dieu, APHP
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
8. januar 2021
Primær fullføring (Forventet)
1. juni 2024
Studiet fullført (Forventet)
1. juni 2024
Datoer for studieregistrering
Først innsendt
11. desember 2020
Først innsendt som oppfylte QC-kriteriene
6. februar 2021
Først lagt ut (Faktiske)
10. februar 2021
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
22. mars 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
21. mars 2022
Sist bekreftet
1. mars 2022
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- APHP201139
- 2020-A02919-30 (Registeridentifikator: IDRCB)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .